CHRM3 codes for the M3 muscarinic acetylcholine receptor that is located on the surface of smooth muscle cells of the detrusor, the muscle that effects urinary voiding. Previously, we reported brothers in a family affected by a congenital prune belly-like syndrome with mydriasis due to homozygous CHRM3 frameshift variants. In this study, we describe two sisters with bladders that failed to empty completely and pupils that failed to constrict fully in response to light, who are homozygous for the missense CHRM3 variant c.352G > A; p.(Gly118Arg). Samples were not available for genotyping from their brother, who had a history of multiple urinary tract infections and underwent surgical bladder draining in the first year of life. He died at the age of 6 years. This is the first independent report of biallelic variants in CHRM3 in a family with a rare serious bladder disorder associated with mydriasis and provides important evidence of this association.
encoding myosin light chain kinase, 8 ACTA2 encoding α-smooth muscle actin, 2 and ACTG2 encoding γ2-smooth muscle actin, 7 all muscle cytoskeletal proteins; and MYLK that codes for myosin light chain kinase, required for myosin activation. 9 In other cases, genes that have been associated with bladder malformations code for proteins implicated in the neuro-muscular circuits required for bladder voiding. 12, 13 As examples, HPSE2 codes for heparanase 2 and LRIG2 codes for leucine rich repeats and immunoglobulin-like domains 2, proteins detected in foetal bladder nerves; variants of these genes are implicated in urofacial syndrome. 5, 6, 14 Also in the neuro-muscular category is CHRM3 that encodes M3, the key acetylcholine receptor expressed by detrusor smooth muscle cells that is required for parasympathetic-driven detrusor contraction and bladder emptying. 2, 13, 15 Weber et al 1 reported a family with six brothers who were born to consanguineous Turkish parents. They had congenital prune belly-like syndrome characterised by hypocontractile bladders that failed to empty completely. Each affected boy available for testing harboured a homozygous frameshift variant of CHRM3, predicted to lead to a truncated protein and thus explaining the hypocontractile bladder phenotype. The affected brothers also had impaired pupillary constriction to light, a notable feature given that the M3 acetylcholine receptor is expressed in pupillary sphincter muscle, mediating its contractions. 15, 16 Furthermore, male mice that carry homozygous targeted loss of function mutations of Chrm3 have a similar syndrome affecting the bladder and the eye. 17 In this report, we present a second family carrying a homozygous variant in CHRM3 associated with familial urinary bladder disease.
| METHODS
The family ( Figure 1A ) was recruited as part of a nationally and internationally sourced cohort of 20 unrelated families with phenotypes overlapping urinary bladder voiding dysfunction of unknown cause. (Table 1) .
She has a clinically unaffected brother (II:1) who was heterozygous for the variant. Her other older brother (II:2) had died at the age of 6 years after a short unspecified illness. He had a history of multiple 
| DISCUSSION
Prune belly syndrome due to biallelic variants in CHRM3 is an ultrarare disorder. No subsequent reports have been published since the original family in 2011. 1 This report represents a second family with bladder disease in individuals carrying a homozygous CHRM3 variant.
In common with the family reported by Weber et al, 1 the affected members in the kindred presented with dysfunctional voiding associated with hypocontractile bladders; moreover, in both families, the disease was present at birth. The current report also emphasises that the CHRM3-associated disease is not sex-limited because, while all clinically affected siblings in the Weber et al 1 report were male, the disease in the family presented here affected two girls and most likely also their brother who died in childhood. In contrast, in mice carrying a homozygous targeted Chrm3 mutation, the overdistended bladder phenotype only manifests in males. 17 This observation might be in part explained by the fact that the male urethra is longer than the female counterpart, so higher intra-vesical pressures are needed to expel urine. In fact, the male phenotype may be more severe in humans, with early deaths only observed in males in this report and that of Weber et al. 1 The precise mechanism whereby males are more severely affected is as yet unclear but may be related to the anatomical differences, including urethral length. In both the current family and the one reported by Weber et al, 1 affected members had impairment of pupillary constriction in response to light. Indeed, the presence of dysfunction of both the bladder and the eye is fully consistent with the hypothesis that M3 function was absent, or severely impaired, in both families. While Weber et al 1 described a homozygous frameshift variant, the current family harboured a homozygous missense variant ( Figure 1B) . Of interest, Pomper et al 19 described a patient who had impaired micturition and pupillary constriction and also had decreased levels of M3 protein in bladder tissue; however, CHRM3 sequencing and copy number analyses were normal. We speculate that this patient may have harboured non-coding variants that affect transcription of CHRM3.
CHRM3 comprises five exons although only one of these is coding.
Therefore, the frameshift variant identified in the original report 1 is likely to escape nonsense-mediated decay and a truncated protein will likely be formed. The missense variant reported here has no effect on splicing in an in vitro system and although it is predicted to result in reduced function, the specific mechanism requires further elucidation.
Unfortunately, CHRM3 genotyping data representing a healthy Malaysian population is not available either publically or could be was present in a male with learning disability, cryptorchidism, short stature and alopecia. 21 A 763 kb duplication encompassing CHRM3
alone was detected in a male with intellectual and developmental delay, autistic behaviour, short stature, and hand anomalies. 22 It is important to note that the parents in the original report and in our family with heterozygous CHRM3 variants are clinically normal. Therefore, these data indicate that dosage effects of CHRM3 may be associated with a clinical developmental phenotype, distinct from the bladder and pupillary phenotype in individuals with biallelic coding variants.
CHRM3 is overexpressed in bladders of adults with benign prostatic hypertrophy, 20 most likely a compensatory response to anatomic bladder outflow obstruction. The M3 acetylcholine receptor is in fact more widely expressed than in the detrusor and ciliary muscles.
Although dilated pupils are present in all affected individuals reported to date with biallelic CHRM3 variants indicating that this is a core feature of the phenotype, the association of bladder dysfunction with mydriasis is not exclusive to individuals with CHRM3 variants. Of note individuals with biallelic pathogenic variants in MYL9 have mydriasis as part of megacystis microcolon intestinal hypoperistalsis phenotype. 11 The similarity in the bladder-eye phenotype in the two families would indicate that the missense variant results in a loss of function comparable to that predicted by the frameshift variant identified by Weber et al. 1 It will be important through murine and cellular studies to undertake functional studies to determine the mechanism of action of the reported disease-associated variants. The report of this second family provides independent evidence that biallelic variants in CHRM3 result in severe bladder voiding dysfunction which on the basis of the families described to date is associated with mydriasis and is more severe, resulting in early lethality, in males.
